Efficacy and Feasibility of Allogeneic Hematopoietic Stem-Cell Transplantation in the Treatment of Refractory Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

Efficacy and Feasibility of Allogeneic Hematopoietic Stem-Cell Transplantation in the Treatment of Refractory Acute Myeloid Leukemia

Published:2019-03 Issue:3 Volume:19 Page:177-182
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Ciftciler Rafiye,Demiroglu Haluk,Buyukasık Yahya,Aladag Elifcan,Aksu Salih,Haznedaroglu Ibrahim C.,Sayınalp Nilgun,Ozcebe Osman,Malkan Umit Yavuz,Goker Hakan

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference32 articles.

1. Adult acute myeloid leukaemia;Smith;Crit Rev Oncol Hematol,2004

2. Standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia;Cheson;J Clin Oncol,2003

3. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet;Döhner;Blood,2010

4. Impact of cytogenetics on the prognosis of adults with de novo AML in first relapse;Weltermann;Leukemia,2004

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High throughput screening aids clinical decision‐making in refractory acute myeloid leukaemia;Cancer Reports;2024-04

2. Early Allogeneic Transplantation Favorably Influences the Outcome of Pediatric Acute Myeloid Leukemia—A Retrospective Study in a Single Center Over 2 Decades;Transplantation Proceedings;2024-01

3. Salvage hematopoietic stem cell transplantation for patients with higher leukemia burden in relapsed or refractory acute myeloid leukemia: a ten-year study;Annals of Hematology;2023-09-08

4. Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: A Single-Centre Experience;Clinical Lymphoma Myeloma and Leukemia;2023-01

5. Alternative donor peripheral blood stem cell transplantation for the treatment of high-risk refractory and/or relapsed childhood acute leukemia: a randomized trial;Experimental Hematology & Oncology;2020-04-06